期刊文献+

Immune Responses and Histopathological Changes in Rabbits Immunized with Inactivated SARS Coronavirus

Immune Responses and Histopathological Changes in Rabbits Immunized with Inactivated SARS Coronavirus
暂未订购
导出
摘要 To evaluate the immunogenicity of inactivated SARS coronavirus(SARS-CoV),three groups of rabbits were immunized three times at 2-week intervals with inactivated vaccine + adjuvant,adjuvant,and normal saline respectively.Eight batchs of serum were sampled from the auricular vein at day 7 to day 51,and specific IgG antibody titers and neutralizing antibody titers were detected by indirect ELISA and micro-cytopathic effect neutralizing test.Antibody specificity was identified by proteinchip assay.Histopathological changes were detected by H&E staining.The results showed that,rabbits in the experimental group immunized with inactivated SARS-CoV all generated specific IgG antibodies with neutralizing activity,which suggested the inactivated SARS-CoV could preserve its antigenicity well and elicit an effective humoral immune responses.The peak titer value of specific IgG antibody and neutralizing antibody reached 1:40960 and 1:2560 respectively.In the experimental group,no obvious histopathological changes was detected in the H&E stained slides of heart,spleen,kidney and testis samples,but the livers had slight histopathological changes,and the lungs presented remarkable histopathological changes.These findings are of importance for SARS-CoV inactivated vaccine development. To evaluate the immunogenicity of inactivated SARS coronavirus(SARS-CoV),three groups of rabbits were immunized three times at 2-week intervals with inactivated vaccine + adjuvant,adjuvant,and normal saline respectively.Eight batchs of serum were sampled from the auricular vein at day 7 to day 51,and specific IgG antibody titers and neutralizing antibody titers were detected by indirect ELISA and micro-cytopathic effect neutralizing test.Antibody specificity was identified by proteinchip assay.Histopathological changes were detected by H&E staining.The results showed that,rabbits in the experimental group immunized with inactivated SARS-CoV all generated specific IgG antibodies with neutralizing activity,which suggested the inactivated SARS-CoV could preserve its antigenicity well and elicit an effective humoral immune responses.The peak titer value of specific IgG antibody and neutralizing antibody reached 1:40960 and 1:2560 respectively.In the experimental group,no obvious histopathological changes was detected in the H&E stained slides of heart,spleen,kidney and testis samples,but the livers had slight histopathological changes,and the lungs presented remarkable histopathological changes.These findings are of importance for SARS-CoV inactivated vaccine development.
出处 《中国病毒学》 CSCD 2007年第5期360-365,共6页 Virologica Sinica
基金 Joint funds of National Natural Science Foundation of China (U0632010) Program of Guangdong Provincial Key Lab of Bioengineering Medicine (51207026).
关键词 免疫反应 组织病理学 急性呼吸综合症 冠状病毒 SARS 疫苗 SARS coronavirus(SARS-CoV) Humoral immune response Histopathological change
  • 相关文献

参考文献18

  • 1Cheng M, Chan C W, Cheung R C, et al. 2005. Crossreactivity of antibody against SARS-coronavirus nucleocapsid protein with IL-11. Bioehem Biophys Res Commun, 338 (3): 1654-1660.
  • 2The Chinese SARS Molecular Epidemiology Consortium. 2004. Molecular evolution of the SARS coronavirus during the course of the SARS epidemic in China. Science, 303 (5664): 1666-1669.
  • 3Drosten C, Gunther S, Preiser W, et al. 2003. Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N Engl J Meal, 348 (20): 1967-1976.
  • 4Ksiazek T G, Erdman D, Goldsmith C S, et al. 2003. A novel coronavirus associated with severe acute respiratory syndrome. N Engl J Med, 348 (20): 1947-1958.
  • 5Lu J H, Yan X G, Guo Z M, et al. 2003. Establishment of SARS virus vaccine line. Guangdong Med J, 24 (SARS Suppl. 2): 194-195.
  • 6Lu J H, Yan X G, Wang Y F, et al. 2003. Study on the function in inactivating antigenicity of SARS coronavirus by formaldehyde. Guangdong Med J, 24 (SARS Suppl. 2) 206-207.
  • 7Marra M A, Jones S J, Astell C R, et al. 2003. The genome sequence of the SARS-associated coronavirus. Science, 300 (5624): 1399-1404.
  • 8Peiris J S M, Lai S T, Poon L L M, et al. 2003. Coronavirus as a possible cause of severe acute respiratory syndrome. Lancet, 361 (9366): 1319-1325.
  • 9Rota P A, Oberste M S, Monroe S S, et al. 2003. Characterization of a novel coronavirus associated with severe acute respiratory syndrome. Science, 300 (5624): 1394-1399.
  • 10Ruan Y J, Wei C L, Ee L A, et al. 2003. Comparative full-length genome sequence analysis of 14 SARS coronavirus isolates and common mutations associated with putative origins of infection. Lancet, 362 (9371): 1779-1787.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部